Skip to content
Clinical Trials – home

SODIUM FLUORIDE (18F): A Radioactive Tracer for Medical Imaging

3 / 3
trials open to patients / all trials
1+
Countries

In short

Sodium Fluoride (18F) is a radioactive tracer used in medical imaging, particularly in PET/CT scans. This article explores its application in clinical trials for various conditions, including fibrous dysplasia/McCune-Albright syndrome and transthyretin amyloid cardiomyopathy. We'll discuss how this tracer is being used to enhance diagnostic capabilities and monitor treatment effectiveness in these studies.

At a glance

Drug Name
Sodium Fluoride (18F)
Primary Use
Radioactive tracer for PET/CT imaging
Conditions Studied
Fibrous Dysplasia/McCune-Albright Syndrome, Transthyretin Amyloid Cardiomyopathy
Administration Method
Intravenous injection
Dosage
Varies, typically measured in MBq/kg
Key Applications
Quantification of bone lesion activity, myocardial microcalcification
Patient Exclusions
Pregnant or breastfeeding women, certain medical conditions

What is SODIUM FLUORIDE (18F)?

SODIUM FLUORIDE (18F), also known as Radio-Flu or Sodium Fluoride F-18, is a radioactive substance used in medical imaging. It's not a medication that treats diseases directly, but rather a diagnostic tool that helps doctors see what's happening inside your body.

Medical Uses

SODIUM FLUORIDE (18F) is primarily used in a type of medical imaging called PET/CT (Positron Emission Tomography/Computed Tomography). This imaging technique is helpful in several medical conditions:

  • Bone disorders: It's being studied in patients with a condition called Fibrous Dysplasia/McCune-Albright Syndrome, a disorder that affects bone development.
  • Heart conditions: Researchers are investigating its use in patients with Transthyretin Amyloid Cardiomyopathy, a heart condition where abnormal proteins build up in the heart.

In these conditions, SODIUM FLUORIDE (18F) can help doctors:

  • Measure the activity of bone lesions (abnormal areas of bone)
  • Quantify microcalcification (tiny deposits of calcium) in the heart muscle
  • Monitor how diseases progress over time
  • Evaluate how well treatments are working

How is it Administered?

SODIUM FLUORIDE (18F) is given as an intravenous injection. This means it's injected directly into a vein, usually in your arm. After the injection, you'll undergo a PET/CT scan, which combines two types of imaging to create detailed pictures of your body.

Dosage Information

The dosage of SODIUM FLUORIDE (18F) can vary depending on the specific use and the patient's characteristics. However, based on the available information:

  • The maximum daily dose is typically around 370 MBq/kg (megabecquerels per kilogram of body weight)
  • In some studies, a dose of 2 MBq/kg is used

It's important to note that the exact dose will be determined by your healthcare provider based on your individual needs and the specific imaging requirements.

Current Clinical Trials

SODIUM FLUORIDE (18F) is currently being studied in several clinical trials:

  1. DEnosumab for the treatment of FIbrous Dysplasia/McCune-Albright Syndrome in adults (DeFiD): This study is using SODIUM FLUORIDE (18F) PET/CT to evaluate the activity of bone lesions in patients with Fibrous Dysplasia/McCune-Albright Syndrome. The imaging will help assess how well a drug called Denosumab works in treating this condition.
  2. i-Care; Quantitative-imaging in cardiac transthyretin amyloidosis: This study is using SODIUM FLUORIDE (18F) PET/CT to measure microcalcification in the heart muscle of patients with Transthyretin Amyloid Cardiomyopathy. The goal is to better understand and monitor this heart condition.

Safety Considerations

While SODIUM FLUORIDE (18F) is generally considered safe for diagnostic use, there are some important considerations:

  • It should not be used in pregnant or breastfeeding women.
  • It may not be suitable for people with severe kidney problems (with an estimated glomerular filtration rate less than 30 mL/min/1.73m2).
  • As with any radioactive substance, its use is carefully controlled to minimize radiation exposure.

Always inform your healthcare provider about all your medical conditions and any medications you're taking before undergoing any procedure involving SODIUM FLUORIDE (18F).

Questions people often ask

Conditions where Sodium Fluoride (18F) is being studied

Each condition opens its own overview and trial list

Trials with Sodium Fluoride (18F)

Recruiting trials first

See all 3 →
Quick filters
  • Participants:Adults
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).